Melanie Jones

Dr. Melanie Jones

Department of Science at the Preparatory School, United States Military Academy, West Point, Mississippi, USA
orcid
Department Head of the Department of Natural Sciences at the...

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2010 in Amino Acids
Verified
Journal Article
Closed access
PDF file
JPJohn T. Pinto
John T. Pinto
JLJeong-In Lee
Jeong-In Lee
RSRaghu Sinha
Raghu Sinha
Melanie JonesMelanie Jones
Melanie Jones
ACArthur J. L. Cooper
Arthur J. L. Cooper

6 August 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
TOTimmy J. O’cOnnell
Timmy J. O’cOnnell
SDSina Dadafarin
Sina Dadafarin
Melanie JonesMelanie Jones
Melanie Jones
TRTomás Rodríguez
Tomás Rodríguez
AGAnvita Gupta
Anvita Gupta
JGJan Geliebter
Jan Geliebter
Thyroid cancer is the most prevalent endocrine malignancy in the United States with greater than 53,000 new cases in 2020. There is a significant gender disparity in disease incidence as well, with women developing thyroid cancer three times more often than men; however, the underlying cause of this disparity is poorly understood. Using RNA-sequencing, we profiled the immune landscape of papillary thyroid cancer (PTC) and identified a significant inverse correlation between androgen receptor (AR) levels and the immune checkpoint molecule PD-L1. The expression of PD-L1 was then measured in an androgen responsive-thyroid cancer cell line. Dihydrotestosterone (DHT) treatment resulted in significant reduction in surface PD-L1 expression in a time and dose-dependent manner. To determine if androgen-mediated PD-L1 downregulation was AR-dependent, we treated cells with flutamide, a selective AR antagonist, and prior to DHT treatment to pharmacologically inhibit AR-induced signaling. This resulted ina> 90% restoration of cell surface PD-L1 expression, suggesting a potential role for AR activity in PD-L1 regulation. Investigation into the AR binding sites showed AR activation impacts NF-kB signaling by increasing IkBα and by possibly preventing NF-kB translocation into the nucleus, reducing PD-L1 promoter activation. This study provides evidence of sex-hormone mediated regulation of immune checkpoint moleculesin vitrowith potential ramification for immunotherapies.

7 April 2023 in Cancers
Verified
Journal Article
Open access
PDF file
AGAnvita Gupta
Anvita Gupta
MCMichelle Carnazza
Michelle Carnazza
Melanie JonesMelanie Jones
Melanie Jones
ZDZbigniew Darzynkiewicz
Zbigniew Darzynkiewicz
DHDorota Halicka
Dorota Halicka
JGJan Geliebter
Jan Geliebter
Thyroid cancer (TC) is the most common endocrine malignancy, with an approximately three-fold higher incidence in women. TCGA data indicate that androgen receptor (AR) RNA is significantly downregulated in PTC. In this study, AR-expressing 8505C (anaplastic TC) (84E7) and K1 (papillary TC) cells experienced an 80% decrease in proliferation over 6 days of exposure to physiological levels of 5α-dihydrotestosterone (DHT). In 84E7, continuous AR activation resulted in G1 growth arrest, accompanied by a flattened, vacuolized cell morphology, with enlargement of the cell and the nuclear area, which is indicative of senescence; this was substantiated by an increase in senescence-associated β-galactosidase activity, total RNA and protein content, and reactive oxygen species. Additionally, the expression of tumor suppressor proteins p16, p21, and p27 was significantly increased. A non-inflammatory senescence-associated secretory profile was induced, significantly decreasing inflammatory cytokines and chemokines such as IL-6, IL-8, TNF, RANTES, and MCP-1; this is consistent with the lower incidence of thyroid inflammation and cancer in men. Migration increased six-fold, which is consistent with the clinical observation of increased lymph node metastasis in men. Proteolytic invasion potential was not significantly altered, which is consistent with unchanged MMP/TIMP expression. Our studies provide evidence that the induction of senescence is a novel function of AR activation in thyroid cancer cells, and may underlie the protective role of AR activation in the decreased incidence of TC in men.

20 April 2021 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Melanie JonesMelanie Jones
Melanie Jones
TOTimmy J. O'COnnell
Timmy J. O'COnnell
HZHong Zhao
Hong Zhao
ZDZgibniew Darzynkiewicz
Zgibniew Darzynkiewicz
AGAnvita Gupta
Anvita Gupta
JGJan Geliebter
Jan Geliebter